Post-earnings recap
Reported
Thu, Nov 5, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported a strong earnings per share, beating expectations significantly. This positive surprise contributed to a 4.21% increase in the stock price. However, without revenue figures or management commentary, investors may need to wait for further details to fully understand the company's performance and outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.32 | N/A | +39.13% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.